Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform
Description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron strain has evolved into highly divergent variants with several sub-lineages. These newly emerging variants threaten the efficacy of available COVID-19 vaccines. To mitigate the
